|
| Press Releases |
|
 |
|
| Monday, July 18, 2016 |
|
|
Singapore Scientists Discover New Pathways Leading to Cancer Progression |
| Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas. more info >> |
|
| Wednesday, July 13, 2016 |
|
|
Study Finds Strong Genetic Risk Factor for Kidney Disease |
| An international research collaboration has discovered a strong genetic risk factor for IgA nephropathy (IgAN) - the most common inflammatory kidney disease worldwide - and related renal dysfunction. more info >> |
|
| Tuesday, July 12, 2016 |
|
|
A New Way to Diagnose and Treat Lung Cancer |
| A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer. more info >> |
|
| Friday, July 8, 2016 |
|
|
A New Way of Looking at Cancer |
| Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have reported that these clusters are unlike what others have assumed previously, potentially opening up new ways to detect and inhibit the spread of cancer. more info >> |
|
| Friday, June 3, 2016 |
|
|
New Material Kills E. Coli Bacteria in 30 Seconds |
| Every day, we are exposed to millions of harmful bacteria that can cause infectious diseases, such as the E. coli bacteria. Now, researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have developed a new material that can kill the E. coli bacteria within 30 seconds. more info >> |
|
| Friday, May 20, 2016 |
|
|
Real-Time Imaging of Embryo Development Could Pave the Way for More Effective Human Reproduction Therapies |
| Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed advanced microscopy technologies to monitor embryo development in real time, revealing how mammalian cells differentiate during the earliest stages of embryonic life. more info >> |
|
| Monday, May 16, 2016 |
|
|
Ipsen partners with IMCB to advance understanding and research of Botulinum Neurotoxin Biology |
| Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical company, and the Institute of Molecular and Cell Biology (IMCB), a research institute under the aegis of the Agency for Science, Technology and Research (A*STAR), Singapore, today announced the signature of a research partnership to study the intracellular trafficking of botulinum neurotoxins (BoNTs) within neurons. more info >> |
|
| Friday, May 13, 2016 |
|
|
New Technique Paves the Way for Drug Targeting to Fight Microbial Resistance |
| Research investigators in Singapore have developed a new high throughput method that identifies how ribonucleic acid (RNA) molecules come together in an unbiased and large-scale manner inside cells. more info >> |
|
| Wednesday, May 11, 2016 |
|
|
Scientists Discover New Technology Breakthrough in Fighting Viral Diseases |
| Today, IBM Research (NYSE: IBM) and Singapore's Institute of Bioengineering and Nanotechnology (IBN) announced that they have identified a new breakthrough macromolecule that could help prevent deadly virus infections with a unique triple-play mechanism that can also help prevent viral drug resistance. more info >> |
|
| Wednesday, February 3, 2016 |
|
|
A*STAR and US EPA to Co-develop Innovative Methods to Assess and Predict the Safety of Chemicals, without Relying on Animal Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and the United States Environmental Protection Agency (EPA) are partnering to develop new approaches to identify chemicals that could pose a risk to human health. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets
Feb 1, 2026 18:00: JST
|
|
|
TCG.Zone Announces Strategic Pivot to High-Value Collectible Assets
Feb 1, 2026 17:00 HKT/SGT
|
|
|
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre
Jan 31, 2026 21:00 HKT/SGT
|
|
|
Five Global Megatrends Highlighted at Open Dialogue Expert Forum at the Russia National Centre
Jan 31, 2026 21:00: JST
|
|
|
日清食品（香港）慈善基金连续第四年支持 香港教育大学精英运动员
Jan 31, 2026 07:21 HKT/SGT
|
|
|
REMSleep Receives Medicare PDAC Coding Approval for Complete DeltaWave Product Portfolio
Jan 31, 2026 02:40 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 22:30: JST
|
|
|
NTT DOCOMO Concludes Partnership Agreement with Aduna to Advance Global Network API Expansion
Jan 30, 2026 22:50 JST
|
|
|
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Jan 30, 2026 21:30 HKT/SGT
|
|
|
SuperX Commences Production at First Global Supply Center
Jan 30, 2026 19:24 HKT/SGT
|
|
|
Quam Plus Financial Proudly Serves as Gold Sponsor, The 3rd Hong Kong Capital Markets Forum 2026 Successfully Concludes
Jan 30, 2026 19:18 HKT/SGT
|
|
|
From Digitization to AI Computing: Cheche Group Inc. (CCG) Partners with Volkswagen DSSO and Cardif Airstar Insurance to Usher in the "Premium Era" of Advanced Smart Driving Insurance
Jan 30, 2026 18:35 HKT/SGT
|
|
|
Nissin Foods (Hong Kong) Charity Fund Supports Elite Athletes from The Education University of Hong Kong for the Fourth Consecutive Year
Jan 30, 2026 18:11 HKT/SGT
|
|
|
日清食品（香港）慈善基金連續第四年支持 香港教育大學精英運動員
Jan 30, 2026 17:57 HKT/SGT
|
|
|
（don't delete）日清食品（香港）慈善基金连续第四年支持 香港教育大学精英运动员
Jan 30, 2026 17:42 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
